| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 5e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 5e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |